DOUGLAS J MCLAUGHLIN

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry WILLOUGHBY HILLS, OH NPI 1023075413

General Payments — all program years on this page

$126,074.78

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 350
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $24,076.93 across 34 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,318.2767
2019 $8,450.1150
2020 $2,356.5719
2021 $8,998.6849
2022 $23,587.4348
2023 $57,286.7983
2024 $24,076.9334

Records — PY2024 (34)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101524255 E.R. Squibb & Sons, L.L.C. $18.19 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105007089 ABBVIE INC. $125.01 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105007091 ABBVIE INC. $18.76 10/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105007093 ABBVIE INC. $2,750.00 11/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118838307 Otsuka Pharmaceutical Development & Commercialization, Inc. $181.54 02/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118838309 Otsuka Pharmaceutical Development & Commercialization, Inc. $42.84 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118838311 Otsuka Pharmaceutical Development & Commercialization, Inc. $28.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118838313 Otsuka Pharmaceutical Development & Commercialization, Inc. $150.08 03/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118838315 Otsuka Pharmaceutical Development & Commercialization, Inc. $3,564.00 03/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118838317 Otsuka Pharmaceutical Development & Commercialization, Inc. $351.00 04/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1120551928 Alkermes, Inc. $116.51 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120551930 Alkermes, Inc. $21.47 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277714 Axsome Therapeutics, Inc. $15.84 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277716 Axsome Therapeutics, Inc. $8.25 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277718 Axsome Therapeutics, Inc. $9.99 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277720 Axsome Therapeutics, Inc. $1,500.00 04/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1148277722 Axsome Therapeutics, Inc. $8.04 04/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148277724 Axsome Therapeutics, Inc. $166.00 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277726 Axsome Therapeutics, Inc. $35.00 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277728 Axsome Therapeutics, Inc. $25.00 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277730 Axsome Therapeutics, Inc. $8,500.00 03/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1148277732 Axsome Therapeutics, Inc. $24.55 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277734 Axsome Therapeutics, Inc. $562.20 03/16/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148277736 Axsome Therapeutics, Inc. $315.27 03/16/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148277738 Axsome Therapeutics, Inc. $24.55 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277740 Axsome Therapeutics, Inc. $75.00 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277742 Axsome Therapeutics, Inc. $20.85 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277744 Axsome Therapeutics, Inc. $1,500.00 07/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1148277746 Axsome Therapeutics, Inc. $17.96 07/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148277748 Axsome Therapeutics, Inc. $20.50 07/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1148277750 Axsome Therapeutics, Inc. $1,500.00 07/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1148277752 Axsome Therapeutics, Inc. $110.43 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148277754 Axsome Therapeutics, Inc. $2,250.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1148277756 Axsome Therapeutics, Inc. $20.10 11/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.